Orozco CJ, Hernández‑Mercado MA, Victoria Campos JL, Morales‑Bernal NE

Idioma: Inglés [English version]
Referencias bibliográficas: 19
Paginas: 114-118
Archivo PDF: 241.90 Kb.

RESUMEN

La enfermedad arterial de múltiples sitios es común en pacientes con afección ateroesclerótica en un lecho vascular, incluyendo las arterias coronarias. La presentación clínica depende del sitio y gravedad del territorio vascular afectado, así como del tiempo de desarrollo de la enfermedad. El abordaje terapéutico se centra en considerar los síntomas específicos de cualquier localización afectada y evaluar el riesgo asociado con la lesión específica, así como implementar el manejo para el control de los factores de riesgo cardiovascular (CV). Presentamos un caso poco habitual sobre un paciente con angina inestable y obstrucción total de los accesos vasculares (radial y femoral) que imposibilitó la revascularización coronaria percutánea. Posteriormente, a través de estudios de imagen cardiovascular no invasivos, se descartó la posibilidad de una cirugía de revascularización coronaria al no contar con anatomía coronaria revascularizable secundario a la enfermedad ateroesclerótica severa y difusa de las arterias coronarias.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Aboyans V, Ricco JB, Bartelink MLE, Björck M, Brodmann M, Cohnert T et al. 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS). Eur Heart J. 2017; 39 (9): 763-816.

2. Jude EB, Oyibo SO, Chalmers N, Boulton AJ. Peripheral arterial disease in diabetic and nondiabetic patients: a comparison of severity and outcome. Diab Car. 2001; 24 (8): 1433-1437.

3. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015; 116 (9): 1509-1526.

4. Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008; 300 (2): 197-208.

5. Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2016; 37 (29): 2315-2381.

6. Roffi M, Patrono C, Collet JP, Mueller C, Valgimigli M, Andreotti F et al. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J. 2016; 37 (3): 267-315.

7. Amsterdam EA, Wenger NK, Brindis RG, Casey DE, Ganiats TG, Holmes DR et al. 2014 AHA/ACC guideline for the management of patients with non–ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. JACC. 2014; 64 (24): e139-e228.

8. Savji N, Rockman CB, Skolnick AH, Guo Y, Adelman MA, Riles T et al. Association between advanced age and vascular disease in different arterial territories: a population database of over 3.6 million subjects. JACC. 2013; 61 (16): 1736-1743.

9. Fowkes FGR, Rudan D, Rudan I, Aboyans V, Denenberg JO, McDermott MM et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013; 382 (9901): 1329-1340.

10. Jeremias A, Gruberg L, Patel J, Connors G, Brown DL. Effect of peripheral arterial disease on in-hospital outcomes after primary percutaneous coronary intervention for acute myocardial infarction. JACC. 2010; 105 (9): 1268-1271.

11. Morillas P, Quiles J, Cordero A, Guindo J, Soria F, Mazón P et al. Prevalence of peripheral arterial disease in patients with acute coronary syndrome (PAMISCA) investigators. Impact of clinical and subclinical peripheral arterial disease in mid-term prognosis of patients with acute coronary syndrome. Am J Cardiol. 2009; 104 (11): 1494-1498.

12. Subherwal S, Bhatt DL, Li S, Wang TY, Thomas L, Alexander KP et al. Polyvascular disease and long-term cardiovascular outcomes in older patients with non–ST-segment–elevation myocardial infarction. Circ Cardiovasc Qual Out. 2012; 5 (4): 541-549.

13. Collet JP, Cayla G, Ennezat PV, Leclercq F, Cuisset T, Elhadad S et al. Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: the randomized AMERICA Study. Inter J Car. 2018; 54: 36-42.

14. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP et al. Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. New Eng J Med. 1996; 335 (18): 1342-1349.

15. Dencker D, Pedersen F, Engstrøm T, Køber L, Højberg S, Nielsen MB et al. Major femoral vascular access complications after coronary diagnostic and interventional procedures: a Danish register study. Inter J Car. 2016; 202: 604-608.

16. Farooq V, Serruys PW, Garcia-Garcia HM, Zhang Y, Bourantas CV, Holmes DR et al. The negative impact of incomplete angiographic revascularization on clinical outcomes and its association with total occlusions: the SYNTAX (Synergy Between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) trial. JACC. 2013; 61 (3): 282-294.

17. Williams B, Menon M, Satran D, Hayward D, Hodges JS, Burke MN et al. Patients with coronary artery disease not amenable to traditional revascularization: prevalence and 3-year mortality. Cath Cardiovasc Interv. 2010; 75 (6): 886-891.

18. Henry TD, Satran D, Hodges JS, Johnson RK, Poulose AK, Campbell AR et al. Long-term survival in patients with refractory angina. Eur Heart J. 2013; 34 (34): 2683-2688.

19. Chow CK, Jolly S, Rao-Melacini P, Fox KA, Anand SS, Yusuf S. Association of diet, exercise, and smoking modification with risk of early cardiovascular events after acute coronary syndromes. Circulation. 2010; 121 (6): 750-758.